Measles virus-induced promotion of dendritic cell maturation by soluble mediators does not overcome the immunosuppressive activity of viral glycoproteins on the cell surface

Eur J Immunol. 2000 Oct;30(10):2741-50. doi: 10.1002/1521-4141(200010)30:10<2741::AID-IMMU2741>3.0.CO;2-N.

Abstract

Measles virus (MV) infection promotes maturation of dendritic cells (DC), but also interferes with DC functions, and MV renders the DC inhibitory for T cell proliferation. We now describe that MV infection triggers the release of type I IFN from monocyte-derived DC (Mo-DC) which contributes to DC maturation. There is no evidence that soluble mediators are released interfering with the stimulatory activity of uninfected DC. Since inhibition of allogeneic T cell proliferation was unaffected by a fusion inhibitory peptide (Z-fFG), MV infection of T cells did not contribute to inhibition. Allogeneic T cell proliferation depended on the percentage of DC expressing MV F/H glycoproteins within the DC population and their surface expression levels, was induced upon addition of UV-inactivated MV to a mixed lymphocyte reaction stimulated by lipopolysaccharide-matured DC, and was not induced by DC infected with a recombinant MV encoding the ectodomain of vesicular stomatitis virus G protein (MG/FV) instead of the MV glycoproteins. Similarly, DC infected with MV, but not with MG/FV inhibited mitogen-induced proliferation of T cells. Thus, a dominant inhibitory signal is delivered to T cells by the MV glycoproteins on the surface of DC overcoming positive signals by co-stimulatory molecules promoted by maturation factors released from infected DC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigen Presentation
  • Antigens, CD / biosynthesis
  • Antigens, Surface / immunology*
  • Antigens, Viral / immunology
  • Autocrine Communication
  • Cell Differentiation
  • Chlorocebus aethiops
  • Dendritic Cells / cytology*
  • Dendritic Cells / drug effects
  • Dendritic Cells / immunology
  • GTP-Binding Proteins*
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology
  • Hemagglutinins, Viral / genetics
  • Hemagglutinins, Viral / immunology*
  • Humans
  • Immune Tolerance / physiology*
  • Interferon-alpha / biosynthesis
  • Interleukin-4 / pharmacology
  • Lipopolysaccharides / pharmacology
  • Lymphocyte Activation
  • Lymphocyte Culture Test, Mixed
  • Measles virus / genetics
  • Measles virus / immunology*
  • Measles virus / radiation effects
  • Membrane Glycoproteins*
  • Myxovirus Resistance Proteins
  • Phytohemagglutinins / pharmacology
  • Protein Biosynthesis
  • Protein Structure, Tertiary
  • Recombinant Fusion Proteins / immunology
  • T-Lymphocytes / immunology
  • Ultraviolet Rays
  • Vero Cells
  • Vesicular stomatitis Indiana virus / genetics
  • Vesicular stomatitis Indiana virus / immunology
  • Viral Envelope Proteins / genetics
  • Viral Envelope Proteins / immunology
  • Viral Fusion Proteins / genetics
  • Viral Fusion Proteins / immunology*

Substances

  • Antigens, CD
  • Antigens, Surface
  • Antigens, Viral
  • G protein, vesicular stomatitis virus
  • Hemagglutinins, Viral
  • Interferon-alpha
  • Lipopolysaccharides
  • Membrane Glycoproteins
  • Myxovirus Resistance Proteins
  • Phytohemagglutinins
  • Recombinant Fusion Proteins
  • Viral Envelope Proteins
  • Viral Fusion Proteins
  • hemagglutinin protein G, measles virus
  • Interleukin-4
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • GTP-Binding Proteins